Evidence map›Paper›PMID 37922976›Full record

ReviewBiochemical pharmacology2023

RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting.

Anastasios Lymperopoulos, Jordana I Borges, Renee A Stoicovy

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Direct Vascular Effects of Angiotensin II (A Systematic Short Review).International journal of molecular sciences · 2024
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Editorial for theInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anastasios LymperopoulosLaboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL 33328-2018, USA. Electronic address: al806@nova.edu.
Jordana I BorgesLaboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL 33328-2018, USA.
Renee A StoicovyLaboratory for the Study of Neurohormonal Control of the Circulation, Department of Pharmaceutical Sciences, Nova Southeastern University Barry and Judy Silverman College of Pharmacy, Fort Lauderdale, FL 33328-2018, USA.
Nova Southeastern University · US

Funding

Trans-omic analysis of epicardial adipose tissue in atrial fibrillationR01HL155718 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GOLDBERGER, JEFFREY J · 2021 to 2024
$2.8M
NHLBI NIH HHS R01 HL155718
6 · The paper itself

Abstract

Angiotensin II (AngII), as an octapeptide hormone normally ionized at physiological pH, cannot cross cell membranes and thus, relies on, two (mainly) G protein-coupled receptor (GPCR) types, AT

Indexed as

Cardiovascular SystemRGS ProteinsAngiotensin IIGTP-Binding ProteinsHumansHypertrophyReceptor, Angiotensin, Type 1Signal TransductionAngiotensin IIGTP-Binding ProteinsReceptor, Angiotensin, Type 1RGS ProteinsAdrenal glandAngiotensin II receptorCardiac hypertrophyG protein-coupled receptorHypertensionRegulator of G protein Signaling proteinSignal transductionVascular remodeling

Identifiers

PMID37922976
PMCPMC10841918
OpenAlexW4388282776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.